These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24092971)

  • 21. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
    Sarode AL; Sandhu H; Shah N; Malick W; Zia H
    Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering pH-sensitive dissolution of lipid-polymer nanoparticles by Eudragit integration impacts plasmid DNA (pDNA) transfection.
    Santhanes D; Zhang H; Wilkins A; John Aitken R; Gannon AL; Liang M
    Eur J Pharm Biopharm; 2024 Jun; 199():114299. PubMed ID: 38643953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and in-vitro evaluation of floating microballoons of indomethacin.
    Bhardwaj P; Chaurasia H; Chaurasia D; Prajapati SK; Singh S
    Acta Pol Pharm; 2010; 67(3):291-8. PubMed ID: 20524432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use.
    Limayem Blouza I; Charcosset C; Sfar S; Fessi H
    Int J Pharm; 2006 Nov; 325(1-2):124-31. PubMed ID: 16872764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and in vitro/in vivo characterization of enteric-coated nanoparticles loaded with the antihypertensive peptide VLPVPR.
    Sun H; Liu D; Li Y; Tang X; Cong Y
    Int J Nanomedicine; 2014; 9():1709-16. PubMed ID: 24729706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alkaline hydrolysis as a tool to determine the association form of indomethacin in nanocapsules prepared with poly(eta-caprolactone).
    Pohlmann AR; Soares LU; Cruz L; da Silveira NP; Guterres SS
    Curr Drug Deliv; 2004 Apr; 1(2):103-10. PubMed ID: 16305375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciprofloxacin hydrochloride-loaded glyceryl monostearate nanoparticle: factorial design of Lutrol F68 and Phospholipon 90G.
    Shah M; Agrawal Y
    J Microencapsul; 2012; 29(4):331-43. PubMed ID: 22251240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of O/S/W process parameters on 17beta-EV loaded nanoparticles properties.
    Khoee S; Hossainzadeh MT
    Colloids Surf B Biointerfaces; 2010 Jan; 75(1):133-40. PubMed ID: 19740631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of multicomponent indomethacin-paracetamol and famotidine loaded nanoparticles for sustained and effective anti-inflammatory therapy.
    Assali M; Zohud N
    Drug Dev Res; 2021 May; 82(3):448-457. PubMed ID: 33263203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and evaluation of matrices of Eudragit with polycarbophil and carbopol for colon-specific delivery.
    Asghar LF; Chandran S
    J Drug Target; 2008 Dec; 16(10):741-57. PubMed ID: 19005938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serratiopeptidase loaded chitosan nanoparticles by polyelectrolyte complexation: in vitro and in vivo evaluation.
    Mali N; Wavikar P; Vavia P
    AAPS PharmSciTech; 2015 Feb; 16(1):59-66. PubMed ID: 25171974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
    Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G
    Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterization of nanocapsules for colon-targeted drug delivery system.
    Kshirsagar SJ; Bhalekar MR; Patel JN; Mohapatra SK; Shewale NS
    Pharm Dev Technol; 2012; 17(5):607-13. PubMed ID: 21428704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Encapsulation of indomethacin using coaxial ultrasonic atomization followed by solvent evaporation.
    Graves RA; Poole D; Moiseyev R; Bostanian LA; Mandal TK
    Drug Dev Ind Pharm; 2008 Apr; 34(4):419-26. PubMed ID: 18401784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymer-lipid hybrid nanoparticles as enhanced indomethacin delivery systems.
    Dalmoro A; Bochicchio S; Nasibullin SF; Bertoncin P; Lamberti G; Barba AA; Moustafine RI
    Eur J Pharm Sci; 2018 Aug; 121():16-28. PubMed ID: 29777855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new process for drug loaded nanocapsules preparation using a membrane contactor.
    Charcosset C; Fessi H
    Drug Dev Ind Pharm; 2005 Dec; 31(10):987-92. PubMed ID: 16316854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
    Rawat M; Saraf S; Saraf S
    AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Encapsulation and sustained release of a model drug, indomethacin, using CO(2)-based microencapsulation.
    Liu H; Finn N; Yates MZ
    Langmuir; 2005 Jan; 21(1):379-85. PubMed ID: 15620328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.